Evaluation of Prognosis in Hormone Receptor–Positive/HER2-Negative and Lymph Node–Negative Breast Cancer With Low Oncotype DX Recurrence Score

88. Validity of Oncotype Dx recurrence score in predicting recurrence in hormone receptor positive and node negative early breast cancer patients

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.094 ◽

2016 ◽

Vol 42 (9) ◽

pp. S103

Author(s):

A. Munir ◽

S. Udyashankar ◽

D. Thomas ◽

G. Dazeley ◽

A. Huws ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

Node Negative ◽

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

SpringerPlus ◽

10.1186/s40064-015-0840-y ◽

2015 ◽

Vol 4 (1) ◽

Cited By ~ 8

Author(s):

Nikhil G Thaker ◽

Karen E Hoffman ◽

Michael C Stauder ◽

Simona F Shaitelman ◽

Eric A Strom ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Node Negative ◽

Node Negative Breast Cancer

Comparison of Oncotype Dx (ODx) 21-gene recurrence score (RS) in African American (AA) and Caucasian (C) patients with hormone receptor-positive (HR+), HER2-negative (HER2-), lymph node-negative (LNN) breast cancer (BC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.620 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 620-620

Author(s):

K. B. Kabaker ◽

J. Canar ◽

R. D. Rao ◽

M. A. Cobleigh

Keyword(s):

Breast Cancer ◽

African American ◽

Lymph Node ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Negative ◽

Hormone Receptor Positive

Clinical significance of 21-gene recurrence score assay for hormone receptor–positive, lymph node-negative breast cancer in early stage

Experimental and Molecular Pathology ◽

10.1016/j.yexmp.2019.04.013 ◽

2019 ◽

Vol 108 ◽

pp. 150-155

Author(s):

Yang Yu-qing ◽

Wang Lei ◽

Huang Mei-ling ◽

Xiao Jing-jing ◽

Wei Mei-chen ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Clinical Significance ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Positive Lymph Node ◽

Node Negative ◽

Node Negative Breast Cancer

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2019.00667 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 2

Author(s):

Mi Jeong Kwon ◽

Jeong Eon Lee ◽

Joon Jeong ◽

Sang Uk Woo ◽

Jinil Han ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Risk Classification ◽

Oncotype Dx ◽

Asian Women ◽

Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.12074 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 12074-12074

Author(s):

Catherine Margaret Kelly ◽

John Crown ◽

Niamh Russell ◽

Stephen Barron ◽

Seodhna Lynch ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Node Negative ◽

Prognostic Performance ◽

Negative Lymph Node ◽

Multigene Signatures

Abstract P5-06-05: Discordant classification and outcomes between Prosigna and Oncotype Dx Recurrence Score for ER-positive, HER2-negative, node-negative breast cancer

10.1158/1538-7445.sabcs19-p5-06-05 ◽

2020 ◽

Author(s):

Ivana Sestak ◽

Sean Ferree ◽

Itay Shemesh ◽

Wesley Buckingham ◽

Jack Cuzick ◽

...

Keyword(s):

Breast Cancer ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Negative ◽

Er Positive ◽

Abstract P5-15-01: Breast cancer specific survival in 38,568 patients with node negative hormone receptor positive invasive breast cancer and oncotype DX recurrence score results in the SEER database

10.1158/1538-7445.sabcs15-p5-15-01 ◽

2016 ◽

Cited By ~ 12

Author(s):

S Shak ◽

VI Petkov ◽

DP Miller ◽

N Howlader ◽

N Gliner ◽

...

Keyword(s):

Breast Cancer ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Breast Cancer Specific Survival ◽

Seer Database ◽

Cancer Specific Survival ◽

Node Negative ◽

146P Prognostic impact of HER2-low expression according to the oncotype Dx recurrence score in hormone receptor-positive early breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.08.427 ◽

2021 ◽

Vol 32 ◽

pp. S424

Author(s):

R. Mutai ◽

T. Barkan ◽

A. Moore ◽

M. Sarfaty ◽

S. Stemmer ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Prognostic Impact ◽

Oncotype Dx Recurrence Score ◽

Low Expression

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer

Cancer Management and Research ◽

10.2147/cmar.s343549 ◽

2021 ◽

Vol Volume 13 ◽

pp. 9411-9420

Author(s):

Bader Alshamsan ◽

Aisha Alshibany ◽

Mahmoud A Elshenawy ◽

Ahmed Badran ◽

Tusneem Elhassan ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Negative ◽

Neutrophil Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Hormonal Receptor ◽